EuropaBio – the European Association for Bioindustries is delighted to invite you to its first public SME BioForum event – “SME BioForum 2022 – the voice of SMEs for a competitive, sustainable and healthy Europe.”
Throughout 2022, EuropaBio SME Platform, representing Europe’s biotechnology SME community across healthcare and industrial biotechnology, organised two inaugural SME BioForum sessions. The Platform gathered European SME executives to discuss the latest biotechnology commercial developments, company challenges, and how the European landscape impacts their ability to grow and deliver products and services to the market.
In our first session dedicated to Advanced Therapy Medicinal Products (ATMPs), SME executives discussed their main challenges to growth, focusing on Europe’s Market fragmentation, Regulatory pathways and other bottlenecks. The second SME BioForum session dedicated to Europe’s Green transition was hosted at EuropaBio’s flagship conference, the European Forum for Industrial Biotechnology and the Bioeconomy in Vilnius, Lithuania. In this session, SME leaders discussed how European SMEs are driving Europe’s Green transition through Biomanufacturing, Incentives for disruptive technologies and Data use and Digital applications.
Closing this year, EuropaBio will host this online event. Our SME participants and European policymakers will join us to present and debate the latest policy developments for ATMPs and Europe’s Green transition and share their recommendations for achieving a competitive, sustainable, healthy Europe.
Join us online for an engaging discussion on December 13, 11h00 – 12h15 CET.
Speakers
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.